The targeting construct introduced the cre recombinase gene fused to the mutant progesterone ligand-binding domain to allow activation by mifepristone or RU486. (J:104190)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count